MedPath

Clinical study on safety of PET probe targeting GLP-1 receptor

Not Applicable
Conditions
healthy subjects
Registration Number
JPRN-UMIN000025288
Lead Sponsor
Kyoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
6
Inclusion Criteria

Not provided

Exclusion Criteria

1)BMI<18.5 or 30.0< 2)complication severe renal dysfunction pancreatic tumor pancreatitis 3)past history pancreatitis pancreatic disease 4)unsuitable for and contraindication to Exenatide 5)alcohol intolerance 6)Inadequate patient judged by doctors

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath